Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,254 | 851 | 55.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,250 | 7 | 41.0% |
| Travel and Lodging | $774.72 | 4 | 2.8% |
| Education | $134.74 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $13,197 | 32 | $0 (2017) |
| ABBVIE INC. | $1,804 | 101 | $0 (2024) |
| Abbott Laboratories | $1,662 | 35 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,308 | 103 | $0 (2024) |
| PFIZER INC. | $728.83 | 77 | $0 (2024) |
| Allergan, Inc. | $702.20 | 47 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $655.68 | 57 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $611.41 | 48 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $489.01 | 33 | $0 (2022) |
| Daiichi Sankyo Inc. | $486.79 | 46 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,224 | 141 | ABBVIE INC. ($521.07) |
| 2023 | $2,543 | 108 | AbbVie Inc. ($721.26) |
| 2022 | $1,840 | 99 | ABBVIE INC. ($399.72) |
| 2021 | $2,203 | 113 | SCILEX PHARMACEUTICALS INC. ($262.15) |
| 2020 | $1,193 | 56 | Vertos Medical, Inc. ($211.33) |
| 2019 | $1,390 | 91 | Scilex Pharmaceuticals Inc. ($193.83) |
| 2018 | $1,486 | 121 | Daiichi Sankyo Inc. ($199.31) |
| 2017 | $14,534 | 134 | Depomed, Inc. ($13,197) |
All Payment Transactions
863 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $142.15 | General |
| Category: Neuromodulation | ||||||
| 12/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Opioid Analgesic | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $2.12 | General |
| Category: Opioid Analgesic | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $8.14 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Analgesic | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $12.12 | General |
| Category: Opioid Analgesic | ||||||
| 11/27/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | Bioventus LLC | SUPARTZ FX SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: DEVICES | ||||||
| 11/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $28.90 | General |
| 11/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Analgesic | ||||||
| 11/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Analgesic | ||||||
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Opioid Analgesic | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: PAIN | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: PAIN | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,394 | 10,061 | $1.9M | $373,604 |
| 2022 | 30 | 2,066 | 8,218 | $1.6M | $322,625 |
| 2021 | 24 | 1,914 | 6,690 | $1.6M | $347,611 |
| 2020 | 23 | 1,294 | 3,326 | $1.1M | $214,347 |
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 358 | 663 | $207,519 | $52,458 | 25.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 254 | 638 | $199,694 | $49,194 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 306 | $135,252 | $34,878 | 25.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 175 | 408 | $110,160 | $30,168 | 27.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 191 | 258 | $224,214 | $23,736 | 10.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 74 | 171 | $70,178 | $19,109 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $74,112 | $18,688 | 25.2% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 18 | 42 | $60,942 | $13,824 | 22.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 81 | 186 | $44,270 | $13,493 | 30.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 37 | 51 | $47,073 | $12,483 | 26.5% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 23 | 23 | $276,000 | $12,254 | 4.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $42,020 | $10,748 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 83 | $33,698 | $9,227 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 57 | $33,687 | $8,745 | 26.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 24 | 30 | $47,792 | $7,411 | 15.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 39 | 53 | $45,393 | $7,197 | 15.9% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 30 | 124 | $32,332 | $6,961 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 35 | $20,927 | $5,855 | 28.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 33 | 45 | $27,682 | $5,456 | 19.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 56 | 90 | $19,800 | $5,219 | 26.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 33 | 48 | $42,620 | $4,565 | 10.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 28 | $12,516 | $3,235 | 25.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 32 | 44 | $13,668 | $2,983 | 21.8% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 16 | 16 | $21,504 | $2,624 | 12.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 11 | 13 | $7,803 | $2,353 | 30.2% |
About Dr. Patrick Annello, M.D
Dr. Patrick Annello, M.D is a Anesthesiology healthcare provider based in Roslyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508066259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Annello, M.D has received a total of $27,413 in payments from pharmaceutical and medical device companies, with $2,224 received in 2024. These payments were reported across 863 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($15,254).
As a Medicare-enrolled provider, Annello has provided services to 7,668 Medicare beneficiaries, totaling 28,295 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Roslyn, NY
- Active Since 07/20/2007
- Last Updated 04/23/2013
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1508066259
Products in Payments
- Nucynta (Drug) $13,175
- BOTOX (Biological) $935.84
- ZTLido (Drug) $913.15
- PROCLAIM (Device) $818.42
- NURTEC ODT (Drug) $757.69
- UBRELVY (Drug) $754.68
- Horizant (Drug) $544.26
- QULIPTA (Drug) $516.60
- RELISTOR (Drug) $443.56
- Movantik (Drug) $443.49
- mild Device Kit (Device) $425.08
- MOVANTIK (Drug) $379.03
- LYRICA (Drug) $358.08
- Omnia (Device) $341.70
- XTAMPZA (Drug) $296.55
- Belbuca (Drug) $286.64
- Amitiza (Drug) $247.69
- RELISTOR ORAL (Drug) $241.15
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $234.97
- LEVORPHANOL TARTRATE (Drug) $168.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Roslyn
Daniel Sajewski, M.d, M.D
Anesthesiology — Payments: $122,137
Bryan Kahan, M.d, M.D
Anesthesiology — Payments: $3,576
Jeffrey Baumel, M.d, M.D
Anesthesiology — Payments: $2,614
Dr. James Widyn, M.d, M.D
Anesthesiology — Payments: $1,721
Zaid Ahmad, M.d, M.D
Anesthesiology — Payments: $1,381
Philip Weinberg, M.d, M.D
Anesthesiology — Payments: $1,368